Concurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia
In conclusion, the current results illustrate that our concurrent chemoradiotherapy regimen was feasible, but disease control remained insufficient. Further research is encouraged in order to improve clinical outcomes.
Source: Journal of Radiation Research - Category: Physics Authors: Ohno, T., Wakatsuki, M., Thinh, D. H. Q., Tung, N. T., Erawati, D., Supriana, N., Beena Devi, C. R., Kato, S., Thephamongkhol, K., Chansilpa, Y., Calaguas, M. J. C., Xiaoting, X., Jianping, C., Banu, P. A., Cho, C.-K., Karasawa, K., Nakano, T., Tsujii, H. Tags: Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Health | International Medicine & Public Health | Nasopharyngeal Cancer | Physics | Study | Toxicology | WHO